
    
      This is a phase 4, prospective, sequential, open-label study designed to evaluate the
      efficacy, safety, and health economic benefits of intraoperative local wound infiltration
      with EXPAREL (bupivacaine liposome injectable suspension) compared with postsurgical
      administration of standardized intravenous (IV) morphine sulfate or Sponsor-approved
      equivalent for postsurgical analgesia in adult patients undergoing ileostomy reversal with
      general anesthesia.
    
  